These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

579 related articles for article (PubMed ID: 25911234)

  • 1. Candida survival strategies.
    Polke M; Hube B; Jacobsen ID
    Adv Appl Microbiol; 2015; 91():139-235. PubMed ID: 25911234
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Variation in biofilm formation among blood and oral isolates of Candida albicans and Candida dubliniensis.
    Villar-Vidal M; Marcos-Arias C; Eraso E; Quindós G
    Enferm Infecc Microbiol Clin; 2011 Nov; 29(9):660-5. PubMed ID: 21899928
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Adherence and biofilm formation of non-Candida albicans Candida species.
    Silva S; Negri M; Henriques M; Oliveira R; Williams DW; Azeredo J
    Trends Microbiol; 2011 May; 19(5):241-7. PubMed ID: 21411325
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Candida species: new insights into biofilm formation.
    Cuéllar-Cruz M; López-Romero E; Villagómez-Castro JC; Ruiz-Baca E
    Future Microbiol; 2012 Jun; 7(6):755-71. PubMed ID: 22702528
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The quorum-sensing molecule E,E-farnesol--its variable secretion and its impact on the growth and metabolism of Candida species.
    Weber K; Schulz B; Ruhnke M
    Yeast; 2010 Sep; 27(9):727-39. PubMed ID: 20641010
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Biofilms of non-Candida albicans Candida species: quantification, structure and matrix composition.
    Silva S; Henriques M; Martins A; Oliveira R; Williams D; Azeredo J
    Med Mycol; 2009 Nov; 47(7):681-9. PubMed ID: 19888800
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Competitive Interactions between C. albicans, C. glabrata and C. krusei during Biofilm Formation and Development of Experimental Candidiasis.
    Rossoni RD; Barbosa JO; Vilela SF; dos Santos JD; de Barros PP; Prata MC; Anbinder AL; Fuchs BB; Jorge AO; Mylonakis E; Junqueira JC
    PLoS One; 2015; 10(7):e0131700. PubMed ID: 26146832
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Factors influencing the virulence of Candida spp.
    Coutinho HD
    West Indian Med J; 2009 Mar; 58(2):160-3. PubMed ID: 21866603
    [TBL] [Abstract][Full Text] [Related]  

  • 9.
    Ponde NO; Lortal L; Ramage G; Naglik JR; Richardson JP
    Crit Rev Microbiol; 2021 Feb; 47(1):91-111. PubMed ID: 33482069
    [No Abstract]   [Full Text] [Related]  

  • 10. Interactions of Both Pathogenic and Nonpathogenic CUG Clade
    Pountain AW; Collette JR; Farrell WM; Lorenz MC
    mBio; 2021 Dec; 12(6):e0331721. PubMed ID: 34903044
    [No Abstract]   [Full Text] [Related]  

  • 11. The importance of strain variation in virulence of Candida dubliniensis and Candida albicans: results of a blinded histopathological study of invasive candidiasis.
    Asmundsdóttir LR; Erlendsdóttir H; Agnarsson BA; Gottfredsson M
    Clin Microbiol Infect; 2009 Jun; 15(6):576-85. PubMed ID: 19604278
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Candida and candidaemia. Susceptibility and epidemiology.
    Arendrup MC
    Dan Med J; 2013 Nov; 60(11):B4698. PubMed ID: 24192246
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Virulence factors of Candida albicans].
    Staniszewska M; Bondaryk M; Piłat J; Siennicka K; Magda U; Kurzatkowski W
    Przegl Epidemiol; 2012; 66(4):629-33. PubMed ID: 23484392
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Clinical isolates and laboratory reference Candida species and strains have varying abilities to form biofilms.
    Alnuaimi AD; O'Brien-Simpson NM; Reynolds EC; McCullough MJ
    FEMS Yeast Res; 2013 Nov; 13(7):689-99. PubMed ID: 23927631
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Candida glabrata, Candida parapsilosis and Candida tropicalis: biology, epidemiology, pathogenicity and antifungal resistance.
    Silva S; Negri M; Henriques M; Oliveira R; Williams DW; Azeredo J
    FEMS Microbiol Rev; 2012 Mar; 36(2):288-305. PubMed ID: 21569057
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Voriconazole inhibits biofilm formation in different species of the genus Candida.
    Valentín A; Cantón E; Pemán J; Martínez JP
    J Antimicrob Chemother; 2012 Oct; 67(10):2418-23. PubMed ID: 22733651
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Comparative analysis of proteinase, phospholipase, hydrophobicity and biofilm forming ability in Candida species isolated from clinical specimens.
    Dabiri S; Shams-Ghahfarokhi M; Razzaghi-Abyaneh M
    J Mycol Med; 2018 Sep; 28(3):437-442. PubMed ID: 29778633
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Candida albicans pathogenicity mechanisms.
    Mayer FL; Wilson D; Hube B
    Virulence; 2013 Feb; 4(2):119-28. PubMed ID: 23302789
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Variation of cell surface hydrophobicity and biofilm formation among genotypes of Candida albicans and Candida dubliniensis under antifungal treatment.
    Borecká-Melkusová S; Bujdáková H
    Can J Microbiol; 2008 Sep; 54(9):718-24. PubMed ID: 18772934
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Prevalence of biofilm formation in clinical isolates of Candida species causing bloodstream infection.
    Pannanusorn S; Fernandez V; Römling U
    Mycoses; 2013 May; 56(3):264-72. PubMed ID: 23113805
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 29.